相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
Song Li et al.
NATURE COMMUNICATIONS (2023)
Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
Yue Zhang et al.
CELLS (2023)
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX , or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Paula Ghaneh et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
Jinguan Lin et al.
ONCOGENE (2022)
KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer
Xin Wu et al.
LIFE SCIENCES (2022)
Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis
Wei Yang et al.
FRONTIERS IN IMMUNOLOGY (2022)
DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
Julie Dardare et al.
FRONTIERS IN ONCOLOGY (2022)
Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma
Xiaofeng Kang et al.
FRONTIERS IN ONCOLOGY (2022)
Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma
Jinzhi Lai et al.
FRONTIERS IN ONCOLOGY (2022)
Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy
Yixin Yin et al.
PHARMACEUTICALS (2022)
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki et al.
DRUG RESISTANCE UPDATES (2022)
Gene regulation by long non-coding RNAs and its biological functions
Luisa Statello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1
Meng Hou et al.
SCIENTIFIC REPORTS (2021)
LPS-induced macrophage HMGB1-loaded extracellular vesicles trigger hepatocyte pyroptosis by activating the NLRP3 inflammasome
Guozhen Wang et al.
CELL DEATH DISCOVERY (2021)
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
Jie Yao et al.
CANCER CELL INTERNATIONAL (2021)
LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit
Senlin Zhao et al.
ONCOGENE (2021)
L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity
Yaodong Yi et al.
TOXICOLOGY (2021)
FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na plus /K plus -ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer
Wen Luo et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
Zhuomao Mo et al.
FRONTIERS IN GENETICS (2020)
Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers
Le Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/β-catenin signalling
Jingsheng Yuan et al.
CELL DEATH & DISEASE (2019)
Long Non-Coding RNA LINC00525 Promotes the Stemness and Chemoresistance of Colorectal Cancer by Targeting miR-507/ELK3 Axis
Shunsheng Wang et al.
INTERNATIONAL JOURNAL OF STEM CELLS (2019)
Tissue Expression Difference between mRNAs and lncRNAs
Lei Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Curcumin mediates oxaliplatinacquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
Vicenc Ruiz de Porras et al.
SCIENTIFIC REPORTS (2016)
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)